Literature DB >> 16030131

Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals.

Hiroshi Takase1, Cheng-Rong Yu, Rashid M Mahdi, Daniel C Douek, Gregory B Dirusso, Frank M Midgley, Rajpreet Dogra, Gloria Allende, Eliot Rosenkranz, Alberto Pugliese, Charles E Egwuagu, Igal Gery.   

Abstract

The majority of maturing T lymphocytes that recognize self-antigens is eliminated in the thymus upon exposure to their target antigens. This physiological process of negative selection requires that tissue-specific antigens be expressed by thymic cells, a phenomenon that has been well studied in experimental animals. Here, we have examined the expression in human thymi of four retinal antigens, that are capable of inducing autoimmune ocular disease retinal S-antigen (S-Ag), recoverin, RPE65 and inter-photoreceptor retinoid-binding protein (IRBP)], as well as four melanocyte-specific antigens, two of which are used as targets for melanoma immunotherapy [gp100, melanoma antigen recognized by T cells 1, tyrosinase-related protein (TRP)-1 and TRP-2]. Using reverse transcription (RT)-PCR, we found that all thymic samples from the 18 donors expressed mRNA transcripts of most or all the eight tested tissue antigens. Yet, the expression of the transcripts varied remarkably among the individual thymic samples. In addition, S-Ag, RPE65 and IRBP were detected by immunostaining in rare cells in sections of human thymi by antibodies against these proteins. Quantitative real-time RT-PCR analysis revealed that the retinal antigen transcripts in the human thymus are present at trace levels, that are lower by approximately five orders of magnitude than those in the retina. Our observations thus support the notions that thymic expression is a common feature for all tissue-specific antigens and that the levels of expression play a role in determining the susceptibility to autoimmunity against these molecules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16030131      PMCID: PMC2366090          DOI: 10.1093/intimm/dxh275

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  37 in total

1.  T cell tolerance to a neo-self antigen expressed by thymic epithelial cells: the soluble form is more effective than the membrane-bound form.

Authors:  Meifen Zhang; Melanie S Vacchio; Barbara P Vistica; Sylvie Lesage; Charles E Egwuagu; Cheng-Rong Yu; Monique P Gelderman; Michael C Kennedy; Eric F Wawrousek; Igal Gery
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

2.  Immune response to retinal antigens in patients with gyrate atrophy and other hereditary retinal dystrophies.

Authors:  S A Tamm; S M Whitcup; I Gery; B Wiggert; R B Nussenblatt; M I Kaiser-Kupfer
Journal:  Ocul Immunol Inflamm       Date:  2001-06       Impact factor: 3.070

3.  Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs.

Authors:  A Pugliese; D Brown; D Garza; D Murchison; M Zeller; M J Redondo; M Redondo; J Diez; G S Eisenbarth; D D Patel; C Ricordi
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

4.  Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells.

Authors:  L Klein; M Klugmann; K A Nave; V K Tuohy; B Kyewski
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

5.  Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes.

Authors:  Aziz Alami Chentoufi; Constantin Polychronakos
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

6.  Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.

Authors:  Maria R Parkhurst; Cormac DePan; John P Riley; Steven A Rosenberg; Suyu Shu
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

Review 7.  Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy.

Authors:  Victor H Engelhard; Timothy N J Bullock; Teresa A Colella; Stacey L Sheasley; David W Mullins
Journal:  Immunol Rev       Date:  2002-10       Impact factor: 12.988

8.  RPE65 is highly uveitogenic in rats.

Authors:  Don-Il Ham; Susan Gentleman; Chi-Chao Chan; J Hugh McDowell; T Michael Redmond; Igal Gery
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

9.  Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice.

Authors:  Karine Thébault-Baumont; Danielle Dubois-Laforgue; Patricia Krief; Jean-Paul Briand; Philippe Halbout; Karine Vallon-Geoffroy; Joëlle Morin; Véronique Laloux; Agnès Lehuen; Jean-Claude Carel; Jacques Jami; Sylviane Muller; Christian Boitard
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

10.  High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire.

Authors:  A C Anderson; L B Nicholson; K L Legge; V Turchin; H Zaghouani; V K Kuchroo
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  18 in total

1.  Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism.

Authors:  Jens Derbinski; Sheena Pinto; Stefanie Rösch; Klaus Hexel; Bruno Kyewski
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-07       Impact factor: 11.205

2.  Proteolytic dynamics of human 20S thymoproteasome.

Authors:  Ulrike Kuckelkorn; Sabine Stübler; Kathrin Textoris-Taube; Christiane Kilian; Agathe Niewienda; Petra Henklein; Katharina Janek; Michael P H Stumpf; Michele Mishto; Juliane Liepe
Journal:  J Biol Chem       Date:  2019-03-26       Impact factor: 5.157

Review 3.  A look at autoimmunity and inflammation in the eye.

Authors:  Rachel R Caspi
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 4.  Thymic epithelial cell heterogeneity: TEC by TEC.

Authors:  Noam Kadouri; Shir Nevo; Yael Goldfarb; Jakub Abramson
Journal:  Nat Rev Immunol       Date:  2019-12-05       Impact factor: 53.106

5.  Cancer-associated retinopathy caused by benign thymoma.

Authors:  Akiko Tanaka; Hiroshi Takase; Grazyna Adamus; Manabu Mochizuki
Journal:  Br J Ophthalmol       Date:  2010-04       Impact factor: 4.638

Review 6.  Immune mechanisms in inflammatory and degenerative eye disease.

Authors:  Victor L Perez; Rachel R Caspi
Journal:  Trends Immunol       Date:  2015-05-13       Impact factor: 16.687

Review 7.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

Review 8.  Recent advances in the genetics of autoimmune disease.

Authors:  Peter K Gregersen; Lina M Olsson
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 9.  Uveitis: Molecular Pathogenesis and Emerging Therapies.

Authors:  Charles E Egwuagu; Sahar A Alhakeem; Evaristus C Mbanefo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

10.  Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.

Authors:  Els M E Verdegaal; Marten Visser; Tamara H Ramwadhdoebé; Caroline E van der Minne; Jeanne A Q M J van Steijn; Ellen Kapiteijn; John B A G Haanen; Sjoerd H van der Burg; Johan W R Nortier; Susanne Osanto
Journal:  Cancer Immunol Immunother       Date:  2011-03-24       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.